Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cerus Corp (NASDAQ:CERS)

Tuesday’s trading has closed, but CERS is being traded in the after-hours session. After-Hours quote »
5.25
Delayed Data
As of 4:14pm ET
 +0.04 / +0.77%
Today’s Change
3.53
Today|||52-Week Range
7.03
-15.87%
Year-to-Date

Today’s Trading

Previous close5.21
Today’s open5.18
Day’s range5.18 - 5.38
Volume462,299
Average volume (3 months)815,839
Market cap$496.9M
Dividend yield--
Data as of 4:14pm ET, 08/04/2015

Growth & Valuation

Earnings growth (last year)+4.69%
Earnings growth (this year)+0.67%
Earnings growth (next 5 years)+35.00%
Revenue growth (last year)-8.17%
P/E ratioNM
Price/Sales13.11
Price/Book10.09

Competitors

 Today’s
change
Today’s
% change
INOInovio Pharmaceutica...-0.10-1.38%
BLCMBellicum Pharmaceuti...+0.06+0.30%
ANIKAnika Therapeutics I...-0.53-1.43%
ANGOAngioDynamics Inc+0.08+0.51%
Data as of 4:14pm ET, 08/04/2015

Financials

Next reporting dateAugust 7, 2015
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$36.4M
Annual profit (last year)-$38.8M
Net profit margin-106.42%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
William Mariner Greenman
Vice President-Manufacturing &
Operations
Suzanne Margerum
Corporate headquarters
Concord, California

Forecasts